Opening Arguments Begin In Opioid MDL Bellwether Trial Of Teva, Allegan, 2 Others
SAN FRANCISCO — Opening arguments began April 15 in San Francisco’s opioid multidistrict litigation bellwether trial involving two drug manufacturers, a distributor and retail pharmacy chain Walgreens....To view the full article, register now.
Already a subscriber? Click here to view full article